Many people still believe kratom is a “natural” or low-risk alternative to opioids. What’s often left out of that conversation is 7-hydroxymitragynine, commonly shortened to 7-OH. This compound is not just another plant alkaloid. It is a powerful opioid-acting substance that binds strongly to the same receptors as morphine and fentanyl.
As highly concentrated kratom extracts and synthetic blends enter the market, 7-OH is increasingly linked to dependence, withdrawal, and overdose risk. At Renewal Recovery, we’re seeing more patients whose opioid use disorder is tied directly to these products.
What Is 7-OH
7-hydroxymitragynine is an active metabolite of mitragynine, the primary compound found in kratom leaves. While mitragynine itself has opioid-like effects, 7-OH is significantly more potent at the mu-opioid receptor.
Key facts:
-
7-OH occurs naturally in small amounts
-
It can also be concentrated or synthesized
-
It acts as a strong opioid agonist
-
Its effects resemble traditional opioids more than stimulants
This is why many kratom products feel far stronger than users expect.
Why 7-OH Is Raising Red Flags
Public health agencies have grown increasingly concerned because modern kratom products are no longer just ground leaves or tea. Many are extracts or enhanced formulations with elevated 7-OH levels.
Risks include:
-
Rapid tolerance development
-
Physical dependence
-
Opioid-type withdrawal symptoms
-
Respiratory depression at higher doses
-
Increased overdose risk when mixed with other substances
In short, 7-OH behaves like an opioid even when marketed as something else.
How 7-OH Affects the Brain
7-OH binds strongly to opioid receptors responsible for pain relief, euphoria, and sedation. Over time, this leads to:
-
Reduced natural endorphin production
-
Increased pain sensitivity when not using
-
Cravings driven by withdrawal relief rather than pleasure
Many users report needing frequent dosing just to feel “normal,” a hallmark of opioid dependence.
Withdrawal From 7-OH
Withdrawal symptoms from 7-OH often surprise people who believed kratom was non-addictive.
Common symptoms include:
-
Anxiety and panic
-
Muscle aches and restlessness
-
Insomnia
-
Nausea and diarrhea
-
Intense cravings
Because the drug occupies opioid receptors, withdrawal can resemble traditional opioid withdrawal rather than caffeine or stimulant withdrawal.
Why People Don’t Realize They’re Using an Opioid
One of the most dangerous aspects of 7-OH is mislabeling.
People often believe:
-
Kratom is herbal and therefore safe
-
They are avoiding opioids
-
They are managing pain or anxiety responsibly
In reality, many are unknowingly maintaining opioid dependence through 7-OH exposure.
Treatment for 7-OH Dependence
Treatment depends on severity, dose, and duration of use. For many patients, medically supervised detox is necessary to manage withdrawal safely.
Treatment options may include:
-
Medical detox with symptom support
-
Buprenorphine-based MAT when appropriate
-
Therapy focused on relapse prevention
-
Education to prevent substitution with similar products
At Renewal Recovery, we treat 7-OH dependence with the same seriousness as any other opioid use disorder.
Why Education Matters
As regulations struggle to keep up with the market, education becomes critical. Many people using 7-OH products do not identify as having an opioid problem until withdrawal or loss of control appears.
Early intervention prevents escalation.
7-OH is not a harmless supplement ingredient. It is a potent opioid compound increasingly present in products marketed as natural alternatives. For many people, it quietly becomes the doorway into opioid dependence.
At Renewal Recovery, we believe people deserve clear information and real support. If kratom or 7-OH has become something you can’t stop using, help is available and recovery is possible.
Frequently Asked Questions about 7-OH
Is 7-OH the same as kratom?
No. 7-OH is a specific opioid-acting compound found in or added to some kratom products.
Can 7-OH cause overdose?
Yes, especially in high doses or when combined with other depressants.
Is withdrawal dangerous?
While usually not life-threatening, it can be severe and lead to relapse without medical support.
Does Renewal Recovery treat kratom or 7-OH dependence?
Yes. We treat all forms of opioid-related dependence, including kratom and 7-OH.
Is 7-OH Legal?
Key
-
Banned (statewide) = kratom (or its key alkaloids) is treated as illegal/controlled statewide
-
Not banned (statewide) = not illegal statewide (may still have local bans, age limits, product rules, or emergency rules)
-
7-OH note = only included when I found explicit statewide action or explicit scheduling language
Sources used for statewide bans and alkaloid scheduling language include a 50-state legal summary PDF and reporting on recent changes.
| State | Statewide ban status | 7-OH note (if explicit) |
|---|---|---|
| Alabama | Banned (statewide) | Often treated as controlled substance (see state law summary) |
| Alaska | Not banned (statewide) | — |
| Arizona | Not banned (statewide) | — |
| Arkansas | Banned (statewide) | Mitragynine + 7-OH scheduled (explicit) |
| California | Not banned (statewide) | Enforcement actions reported; statewide legality has been contested in practice |
| Colorado | Not banned (statewide) | — |
| Connecticut | Not banned (statewide) | — |
| Delaware | Not banned (statewide) | — |
| Florida | Not banned (statewide) | 7-OH ban announced (state action reported) |
| Georgia | Not banned (statewide) | — |
| Hawaii | Not banned (statewide) | — |
| Idaho | Not banned (statewide) | — |
| Illinois | Not banned (statewide) | — |
| Indiana | Banned (statewide) | Mitragynine + 7-OH treated as Schedule I via “synthetic drug” definition |
| Iowa | Not banned (statewide) | — |
| Kansas | Not banned (statewide) | — |
| Kentucky | Not banned (statewide) | — |
| Louisiana | Banned (statewide) | Listed among banned states in recent reporting |
| Maine | Not banned (statewide) | — |
| Maryland | Not banned (statewide) | — |
| Massachusetts | Not banned (statewide) | — |
| Michigan | Not banned (statewide) | — |
| Minnesota | Not banned (statewide) | — |
| Mississippi | Not banned (statewide) | — |
| Missouri | Not banned (statewide) | — |
| Montana | Not banned (statewide) | — |
| Nebraska | Not banned (statewide) | — |
| Nevada | Not banned (statewide) | — |
| New Hampshire | Not banned (statewide) | — |
| New Jersey | Not banned (statewide) | — |
| New Mexico | Not banned (statewide) | — |
| New York | Not banned (statewide) | — |
| North Carolina | Not banned (statewide) | — |
| North Dakota | Not banned (statewide) | — |
| Ohio | Not banned (statewide) | Emergency rule restricts many kratom products involving 7-OH; leaf/mitragynine-only treated differently |
| Oklahoma | Not banned (statewide) | — |
| Oregon | Not banned (statewide) | — |
| Pennsylvania | Not banned (statewide) | — |
| Rhode Island | Banned (statewide) until April 2026 (reported) | Reported reversal to regulation planned April 2026 |
| South Carolina | Not banned (statewide) | — |
| South Dakota | Not banned (statewide) | — |
| Tennessee | Not banned (statewide) | — |
| Texas | Not banned (statewide) | Synthetic alkaloids restricted; 7-OH concentration limits in state guidance |
| Utah | Not banned (statewide) | — |
| Vermont | Banned (statewide) | Listed as controlled in state law summary |
| Virginia | Not banned (statewide) | — |
| Washington | Not banned (statewide) | — |
| West Virginia | Not banned (statewide) | — |
| Wisconsin | Banned (statewide) | Kratom/7-OH scheduled (explicit) |
| Wyoming | Not banned (statewide) | — |
| District of Columbia | Banned (DC-wide) | 7-OH scheduled via regulation (explicit) |
Sources
- U.S. Food and Drug Administration. (2025). 7-Hydroxymitragynine (7-OH): An assessment of scientific data and toxicological concerns. U.S. Food and Drug Administration. https://www.fda.gov/files/drugs/published/7-hydroxymitragynin_7-oh_an_assessment_of_the_scientific_data_and_toxicological_concerns_around_an_emerging_opioid_threat.pdf
- U.S. Food and Drug Administration. (2025, July 29). FDA takes steps to restrict 7-OH opioid products threatening American consumers. U.S. Department of Health and Human Services. https://www.hhs.gov/press-room/fda-7-oh-scheduling-recommendation.html
- Texas Department of State Health Services. (2025, September 2). Serious illnesses associated with 7-OH use. Texas DSHS. https://www.dshs.texas.gov/news-alerts/serious-illnesses-associated-7-oh-use
- Missouri Department of Health and Senior Services. (n.d.). 7-OH and kratom. Missouri DHSS. https://health.mo.gov/safety/foodsafety/kratom/index.php
- University of Colorado Anschutz Medical Campus. (2025, August 26). What is 7-OH and why it’s being targeted in kratom products. CU Anschutz News. https://news.cuanschutz.edu/news-stories/what-is-7-oh-and-why-is-it-being-targeted-in-kratom-products
- Kruegel, A. C., & Grundmann, O. (2019). 7-Hydroxymitragynine is an active metabolite of mitragynine with opioid activity. ACS Central Science. https://pubs.acs.org/doi/10.1021/acscentsci.9b00141
John Ingham is a nationally respected mental health and addiction recovery advocate with nearly a decade of professional and lived experience—from overcoming heroin and meth addiction to shaping public health policy alongside White House appointees, state legislators, and Nashville’s Ryan White Foundation. Based in Sparta, Tennessee, he has influenced landmark legislation (HB1486), lectured at UT Austin and Vanderbilt, appeared in an Emmy-winning documentary, and driven go-to-market strategies for behavioral health centers. A pioneer in telehealth and patient-centered care, John and his wife also steward a 7-acre homestead, and he looks forward to becoming a father in October 2025—all while building a legacy of truth, recovery, and community.
- John Ingham
- John Ingham
- John Ingham
